Risultati della ricerca - Jun-Peng Lin

The role of neoadjuvant therapy in elderly patients with T1b-T2N + esophageal cancer: a population-based cohort study di Jun-Peng Lin, Jia-Huang Hong, Feng-Nian Zhuang, Hao He, Yu-Jie Chen, Shuo-Yan Liu, Feng Wang

Testo

Prognosis and risk factors for pathological non-response to neoadjuvant chemoimmunotherapy in locally advanced esophageal squamous cell carcinoma di Jun-Peng Lin, Jun-Peng Lin, Jun-Peng Lin, Jun-Peng Lin, Hui Lin, Hui Lin, Hui Lin, Hao He, Hao He, Hao He, Feng-Nian Zhuang, Feng-Nian Zhuang, Feng-Nian Zhuang, Wei-Jie Chen, Wei-Jie Chen, Wei-Jie Chen, Yu-Jie Chen, Yu-Jie Chen, Yu-Jie Chen, Peiyuan Wang, Peiyuan Wang, Peiyuan Wang, Peiyuan Wang, Hang Zhou, Hang Zhou, Hang Zhou, Wen-Wei Wei, Wen-Wei Wei, Wen-Wei Wei, Peng-Qiang Gao, Peng-Qiang Gao, Peng-Qiang Gao, Shuo-Yan Liu, Shuo-Yan Liu, Shuo-Yan Liu, Feng Wang, Feng Wang, Feng Wang, Feng Wang

Testo

Safety and Efficacy of Camrelizumab in Combination With Nab-Paclitaxel Plus S-1 for the Treatment of Gastric Cancer With Serosal Invasion di Ju-Li Lin, Ju-Li Lin, Jian-Xian Lin, Jian-Xian Lin, Jian-Xian Lin, Jun Peng Lin, Jun Peng Lin, Chao-Hui Zheng, Chao-Hui Zheng, Ping Li, Ping Li, Ping Li, Jian-Wei Xie, Jian-Wei Xie, Jia-bin Wang, Jia-bin Wang, Jia-bin Wang, Jun Lu, Jun Lu, Qi-Yue Chen, Qi-Yue Chen, Chang-Ming Huang, Chang-Ming Huang, Chang-Ming Huang

Testo

Complete blood count-based inflammatory score (CBCS) is a novel prognostic marker for gastric cancer patients after curative resection di Jian-Xian Lin, Jun-Peng Lin, Jian-Wei Xie, Jia-bin Wang, Jun Lu, Qi-Yue Chen, Long-long Cao, Mi Lin, Ruhong Tu, Chao-Hui Zheng, Chang-Ming Huang, Ping Li

Testo

Neoadjuvant chemoimmunotherapy versus neoadjuvant chemoradiotherapy in patients with borderline resectable esophageal squamous cell carcinoma di Jun-Peng Lin, Feng-Nian Zhuang, Wei-Jie Chen, Zhou Lin, Yu-Jie Chen, Xiao-Feng Chen, Hui Lin, Hao He, Peiyuan Wang, Hang Zhou, Wen-Wei Wei, Peng-Qiang Gao, Shuo-Yan Liu, Feng Wang

Testo